Literature DB >> 4620441

Corynebacterium parvum as an immunotherapeutic anticancer agent.

M T Scott.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4620441

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  37 in total

1.  Enhanced resistance against Junin virus infection induced by Corynebacterium parvum.

Authors:  D B Budzko; J Casals; B H Waksman
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Antibody to Corynebacterium parvum in normal human and animal sera.

Authors:  G Wolberg; G S Duncan; C Adlam; J K Whisnant
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.

Authors:  S R Watson; V S Sljivić
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

4.  Peritoneal macrophage activation indicated by enhanced chemiluminescence.

Authors:  C J Schleupner; L A Glasgow
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Characterization of mouse peritoneal exudate and associated leukocyte adherence inhibitory activity after intraperitoneal injection of either Bordetella pertussis or Corynebacterium parvum vaccines.

Authors:  T W Klein; S H Pross; W R Benjamin
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

6.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

Authors:  J Taverne; N Matthews; P Depledge; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Immunotherapy of cancer.

Authors:  E C Holmes; D L Morton; F R Eilber
Journal:  West J Med       Date:  1977-02

8.  Mitogenicity of Corynebacterium parvum for mouse lymphocytes.

Authors:  H Zola
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

9.  Enhancement of resistance and suppression of immunization against experimental Trypanosoma cruzi infection by Corynebacterium parvum.

Authors:  F Kierszenbaum
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

10.  Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; K Munk
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.